Home › Entities › clinical_trial › Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma

Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma

clinical trial
MedicalStudy clinical_trial Q63337231
Press Enter · cited answer in seconds

Summary

Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma is a clinical trial[1].

Key Facts

  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma is in the country of France[2].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's instance of is recorded as clinical trial[3].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's start time is recorded as +2011-02-28T00:00:00Z[4].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's end time is recorded as +2013-12-31T00:00:00Z[5].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's sponsor is recorded as Centre Oscar Lambret[6].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's main subject is recorded as sarcoma[7].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's number of participants is recorded as {'unit': '1', 'amount': '+53'}[8].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's title is recorded as Phase II Randomized Trial to Evaluate Two Strategies: Continuing Versus Intermittent (Drug-holiday) Trabectedin-regimen in Patients With Advanced Soft Tissue Sarcoma Experiencing Response or Stable Disease After the Sixth Cycle[9].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's short name is recorded as T-DIS[10].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's ClinicalTrials.gov ID is recorded as NCT01303094[12].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research intervention is recorded as trabectedin[13].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's clinical trial phase is recorded as phase II clinical trial[14].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research site is recorded as Jean Perrin Center[15].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research site is recorded as Centre Oscar Lambret[16].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research site is recorded as Curie Institute[17].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research site is recorded as Centre Henri-Becquerel[18].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research site is recorded as Institut Claudius Regaud[19].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's research site is recorded as Institut Gustave Roussy[20].
  • Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma's study type is recorded as interventional study[21].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma. Retrieved May 3, 2026, from https://4ort.xyz/entity/continuing-vs-intermittent-trabectedin-in-patients-with-advanced-soft-tissue-sarcoma
MLA “Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/continuing-vs-intermittent-trabectedin-in-patients-with-advanced-soft-tissue-sarcoma.
BibTeX @misc{4ortxyz_continuing-vs-intermittent-trabectedin-in-patients-with-advanced-soft-tissue-sarcoma_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma}}, year = {2026}, url = {https://4ort.xyz/entity/continuing-vs-intermittent-trabectedin-in-patients-with-advanced-soft-tissue-sarcoma}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma — https://4ort.xyz/entity/continuing-vs-intermittent-trabectedin-in-patients-with-advanced-soft-tissue-sarcoma (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/continuing-vs-intermittent-trabectedin-in-patients-with-advanced-soft-tissue-sarcoma · Last refreshed: